Melio's platform quickly & accurately identifies DNA/RNA sequences by combining novel DNA melting analysis & AI. The platform assay and device is agnostic to the target sequence being profiled which allows us to uncover novel targets.
Breakthrough Infectious Disease Diagnostics
Melio is developing clinically actionable, neat-patient pathogen identification platform for testing of all common infections. Our untargeted platform profiles each pathogen cell present in the sample in tens of thousands of parallel reactions by capturing their unique sequence specific DNA melting profile. The platform allows us to identify known common bacterial, fungal and viral targets in the sample and also discover novel emerging threats.
Single test, definitive diagnosis
Avoid shotgun treatments
Detect novel emerging threats